Upcoming Webinar to Discuss Immunotherapies for Multiple Myeloma Patients
May 07, 2014 |
On Thursday, May 15, 2014, Hearn Jay Cho, M.D., Ph.D., an assistant professor of medicine, hematology, and medical oncology at Mount Sinai Hospital, will discuss current immunotherapy treatment options for patients with multiple myeloma, and how close we are to making these treatments available to more patients.
This 45-minute online webinar, which is part of the Cancer Research Institute's Breakthroughs in Cancer Immunotherapy webinar series, is free to the public, but registration is limited, so sign up now.
This 45-minute online webinar, which is part of the Cancer Research Institute's Breakthroughs in Cancer Immunotherapy webinar series, is free to the public, but registration is limited, so sign up now
. - See more at: http://cancerresearch.org/news-publications/our-blog/march-2014/can-the-immune-system-see-colorectal-cancer#sthash.foQe1yw4.dpuf
Hearn Jay Cho, M.D., Ph.D.
"Immunotherapy for Multiple Myeloma"
May 15, 2014, at 2:00 p.m. EDT
Dr. Cho’s laboratory is investigating novel therapies targeting the type I Melanoma Antigen GEnes (MAGE) CT7 (MAGE-C1) and MAGE-A3 in multiple myeloma. Dr. Cho received his undergraduate degree in molecular biology from Princeton University and graduated from the Tri-Institutional MD-PhD Program of Cornell University Medical College with a doctoral degree in immunology. He was a resident in the Clinical Investigator Track in the Department of Internal Medicine at the University of California, San Diego, where he also did a postdoctoral research fellowship in immunology. He completed his clinical fellowship in hematology and medical oncology at The New York-Presbyterian Hospital/Weill Cornell Medical College and was a visiting research fellow at The Rockefeller University.